RecruitingAsthma

Registry of Asthma Characterization and Recruitment 3 (RACR3)

Eligible age

All ages

Accepts

All genders

Locations

6 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

You may qualify if…

✓ 1. Participant is either:
✓ 1. At least 18 years old, willing and able to provide informed consent at the time of enrollment
✓ 2. Under the age of 18, accompanied by a legal guardian who is willing and able to provide informed consent at the time of enrollment
✓ 2. Participant has a primary place of residence within the Office of Management and Budget (OMB)-defined Metropolitan Statistical Area (MSA)

You may not qualify if…

✕ 1. Participant does not speak English or Spanish and/or guardian does not speak English or Spanish
✕ 2. Participant does not have access to a phone, either personal or public, with regularity that could be used for scheduling and safety follow-up
✕ 3. Past or current medical problems or findings from physical examination or laboratory testing, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may affect the quality or interpretation of the data obtained from the study
✕ Participants who are pregnant or lactating will not be excluded or discontinued from the study, but will not undergo any procedures that are prohibited during pregnancy per the Childhood Asthma in Urban Settings 02 (CAUSE-02) Registry for Asthma Characterization and Recruitment 3 (RACR3) Manual of Procedures (MOP)(e.g., allergen skin testing, spirometry) during the pregnancy.
✕ Potential participants may be reassessed as outlined in the Protocol CAUSE-02 MOP.

Where it's recruiting

Aurora

Washington D.C.

Chicago

Boston

Cincinnati

Source: ClinicalTrials.gov · NCT05272241 · last updated 2025-06-22